BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26556778)

  • 1. A randomised assessment of the use of a quality of life questionnaire with or without intervention in patients attending a thoracic cancer clinic.
    Nimako K; Ayite B; Priest K; Severn J; Fries HM; Gunapala R; Bhosle J; Popat S; O'Brien M
    Eur J Cancer Care (Engl); 2017 Jul; 26(4):. PubMed ID: 26556778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of Life in NSCLC Survivors - A Multicenter Cross-Sectional Study.
    Hechtner M; Eichler M; Wehler B; Buhl R; Sebastian M; Stratmann J; Schmidberger H; Gohrbandt B; Peuser J; Kortsik C; Nestle U; Wiesemann S; Wirtz H; Wehler T; Bals R; Blettner M; Singer S
    J Thorac Oncol; 2019 Mar; 14(3):420-435. PubMed ID: 30508641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life in patients with lung cancer: validation of the Mexican-Spanish version and association with prognosis of the EORTC QLQ-LC13 questionnaire.
    Arrieta Ó; Núñez-Valencia C; Reynoso-Erazo L; Alvarado S; Flores-Estrada D; Angulo LP; Oñate-Ocaña LF
    Lung Cancer; 2012 Jul; 77(1):205-11. PubMed ID: 22387006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does a patient-held quality-of-life diary benefit patients with inoperable lung cancer?
    Mills ME; Murray LJ; Johnston BT; Cardwell C; Donnelly M
    J Clin Oncol; 2009 Jan; 27(1):70-7. PubMed ID: 19029416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An international study to revise the EORTC questionnaire for assessing quality of life in lung cancer patients.
    Koller M; Hjermstad MJ; Tomaszewski KA; Tomaszewska IM; Hornslien K; Harle A; Arraras JI; Morag O; Pompili C; Ioannidis G; Georgiou M; Navarra C; Chie WC; Johnson CD; Himpel A; Schulz C; Bohrer T; Janssens A; Kuliś D; Bottomley A
    Ann Oncol; 2017 Nov; 28(11):2874-2881. PubMed ID: 28945875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer.
    Brown J; Thorpe H; Napp V; Fairlamb DJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG; Stephens RJ; Waller D; West P; Peake MD
    J Clin Oncol; 2005 Oct; 23(30):7417-27. PubMed ID: 16157935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural distress screening and supportive care for patients with lung cancer on systemic therapy: A randomised controlled trial.
    Geerse OP; Hoekstra-Weebers JE; Stokroos MH; Burgerhof JG; Groen HJ; Kerstjens HA; Hiltermann TJ
    Eur J Cancer; 2017 Feb; 72():37-45. PubMed ID: 28024265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale.
    Gebbia V; Lorusso V; Galetta D; Caruso M M; Palomba G; Riccardi F; Borsellino N; Carrozza F; Leo S; Ferraù F; Cinieri S; Mancuso G; Mancarella S; Colucci G
    Lung Cancer; 2010 Aug; 69(2):218-24. PubMed ID: 19910076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An exercise prescription for patients with lung cancer improves the quality of life, depression, and anxiety.
    Lei J; Yang J; Dong L; Xu J; Chen J; Hou X; Bai Z
    Front Public Health; 2022; 10():1050471. PubMed ID: 36466452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-cultural verification of the EORTC QLQ-C15-PAL questionnaire in mainland China.
    Zhang L; Wang N; Zhang J; Liu J; Luo Z; Sun W; Woo SM; Chen C; Zhang K; Miller AR; Guo H; Zhang X; Wang C
    Palliat Med; 2016 Apr; 30(4):401-8. PubMed ID: 26121985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life during 5 years after stereotactic radiotherapy in stage I non-small cell lung cancer.
    Ubels RJ; Mokhles S; Andrinopoulou ER; Braat C; van der Voort van Zyp NC; Aluwini S; Aerts JG; Nuyttens JJ
    Radiat Oncol; 2015 Apr; 10():98. PubMed ID: 25896787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study on quality of life after thoracoscopic assistant lobectomy for lung cancer].
    Zeng J; Liu J
    Zhongguo Fei Ai Za Zhi; 2014 Mar; 17(3):209-14. PubMed ID: 24667257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial.
    Bendixen M; Jørgensen OD; Kronborg C; Andersen C; Licht PB
    Lancet Oncol; 2016 Jun; 17(6):836-844. PubMed ID: 27160473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21.
    Bezjak A; Tu D; Seymour L; Clark G; Trajkovic A; Zukin M; Ayoub J; Lago S; de Albuquerque Ribeiro R; Gerogianni A; Cyjon A; Noble J; Laberge F; Chan RT; Fenton D; von Pawel J; Reck M; Shepherd FA;
    J Clin Oncol; 2006 Aug; 24(24):3831-7. PubMed ID: 16921034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in patients with lung cancer: a review of literature from 1970 to 1995.
    Montazeri A; Gillis CR; McEwen J
    Chest; 1998 Feb; 113(2):467-81. PubMed ID: 9498968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors of overall well-being using the EORTC QLQ-C15-PAL extracted from the EORTC QLQ-C30.
    Lam K; Zeng L; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Sahgal A; Poon M; Chow E
    J Palliat Med; 2013 Apr; 16(4):402-8. PubMed ID: 23458649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.
    Kemmler G; Holzner B; Kopp M; Dünser M; Margreiter R; Greil R; Sperner-Unterweger B
    J Clin Oncol; 1999 Sep; 17(9):2932-40. PubMed ID: 10561373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer.
    Langendijk JA; Aaronson NK; de Jong JM; ten Velde GP; Muller MJ; Lamers RJ; Slotman BJ; Wouters EF
    J Clin Oncol; 2001 Apr; 19(8):2123-33. PubMed ID: 11304764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL.
    Caissie A; Nguyen J; Chen E; Zhang L; Sahgal A; Clemons M; Kerba M; Arnalot PF; Danjoux C; Tsao M; Barnes E; Holden L; Danielson B; Chow E
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1238-45. PubMed ID: 22172909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.